INKT MiNK Therapeutics Inc.: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik minktherapeutics.com (INKT)

MiNK Therapeutics, Inc. (INKT) is developing an innovative iNKT therapy platform across US centers. The EV-to-revenue ratio illustrates the market response, while the 183650.00 metric confirms the current level. Pipeline diversification across solid and hematological tumors mitigates failure risks. Patents and strict FDA oversight protect the business, creating high barriers to entry for new players in the sector.

Nilai perusahaan marang pendapatan: MiNK Therapeutics Inc. (INKT) kanggo 23.11.2025 - 20.11.2026

minktherapeutics.com - rincian analitis lan metrik utama (INKT)

- rega saham lan konsensus proyeksi valuasi:
- informasi babagan dhuwit lan arus kas:
Analisis wiwitan perusahaan:MiNK Therapeutics, Inc. INKT
Sampel barang MiNK Therapeutics, Inc.

For the biotechnology sector, where MiNK Therapeutics, Inc. (INKT) is developing innovative allogeneic iNKT cell-based therapy, this indicator serves as a tool for assessing the business's market value relative to its operational efficiency. By analyzing the EV/Sales multiple chart, an investor can see the ratio of enterprise value (market capitalization plus debt minus cash) to revenue, which allows for an assessment of the fundamental value of the unique cancer-fighting platform without distortions from debt load.

Analisis pesaing MiNK Therapeutics, Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP